
About Ivy Nelson Pharmaceuticals Private Limited
Data last updated:
Ivy Nelson Pharmaceuticals Private Limited was a private limited company based in Piplod, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 November 2013.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2013PTC077660. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It was led by directors including Rakesh Kumar Verma and Ritesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at B – 20 Puspam Row House, Piplod, Gujarat, India – 394370.
As per the financials filed for FY 2019, the company reported a revenue of ₹19.48 Lakh, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹18,994 (net margin -1%) and EBITDA of -₹16,320 (EBITDA margin -0.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The last known website on record is ivynelson.com.
Company details
Contact details
Ivy Nelson Pharmaceuticals Private Limited's registered office is in Piplod, Gujarat. Its website is ivynelson.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 20 Puspam Row House, Piplod, Gujarat, India – 394370
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ivy Nelson Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
Financials of Ivy Nelson Pharmaceuticals Private Limited
FY 2019 filings availableIvy Nelson Pharmaceuticals Private Limited reported revenue of ₹19.48 Lakh (down 14% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over three years, including a 14% fall in the latest year. EBITDA rose 81% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹19.48 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹16,320 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹18,994 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ivy Nelson Pharmaceuticals Private Limited
Ivy Nelson Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Kumar | Additional Director | 02 Sep 2016 | 10 Years 2 Months | As last reported |
| Manoj Kumar Srivastava | Additional Director | 02 Sep 2016 | 10 Years 2 Months | As last reported |
| Rakesh Kumar Verma Also directs: Ivylivecare Pharmaceuticals Private Limited | Director | 28 Nov 2013 | 12 Years 11 Months | As last reported |
Peer comparison
Ivy Nelson Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rashrinivas Pharmaceuticals Private Limited | ₹19.54 Lakh (FY 2024) | 35.0% | Hyderabad, Telangana, India | |||
| Mercyking Pharmaceuticals Private Limited | ₹19.52 Lakh (FY 2024) | -22.0% | Panvel, Maharashtra, India | |||
| Biojen Pharmaceuticals Private Limited | ₹19.49 Lakh (FY 2025) | -67.0% | Delhi, India | |||
| Ivy Nelson Pharmaceuticals Private Limitedthis company | ₹19.48 Lakh (FY 2019) | -₹18,994 | -1% | -14.0% | Piplod, Gujarat, India | |
| Bromartis Pharmaceuticals Private Limited | ₹19.45 Lakh (FY 2017) | -78.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
Auditor
Ivy Nelson Pharmaceuticals Private Limited is audited by PAWAN MEERA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PAWAN MEERA & CO | FY 2018 | 010536C |
Shareholding
The shareholding of Ivy Nelson Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ivy Nelson Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ivy Nelson Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ivy Nelson Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ivy Nelson Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ivy Nelson Pharmaceuticals Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Sumit Kumar ceased to be Director on 05 Sep 2019.
Frequently asked questions
Ivy Nelson Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ivy Nelson Pharmaceuticals was a private limited company based in Piplod, Gujarat, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 November 2013 and is registered under CIN U24230GJ2013PTC077660. The company has been struck off by the Registrar of Companies and is no longer operational.
Ivy Nelson Pharmaceuticals had 3 directors:
- Ritesh Kumar - Additional Director
- Manoj Kumar Srivastava - Additional Director
- Rakesh Kumar Verma - Director
The CIN (Corporate Identification Number) of Ivy Nelson Pharmaceuticals is U24230GJ2013PTC077660. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ivy Nelson Pharmaceuticals is at B – 20 Puspam Row House, Piplod, Gujarat, India – 394370.
Ivy Nelson Pharmaceuticals was incorporated on 28 November 2013. It is registered with the Registrar of Companies, Ahmedabad.
Ivy Nelson Pharmaceuticals can be reached through the website ivynelson.com. Its registered office is in Piplod, Gujarat, India.
The latest financial statements of Ivy Nelson Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Ivy Nelson Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Ivy Nelson Pharmaceuticals operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
The peers of Ivy Nelson Pharmaceuticals by revenue are Rashrinivas Pharmaceuticals Private Limited, Mercyking Pharmaceuticals Private Limited, Biojen Pharmaceuticals Private Limited, Bromartis Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

